Atlas Trials

A Study of SHR-4394 Injection in Subjects With Prostate Cancer

Clinical trial NCT06783829 · RECRUITING

Trial details

NCT number
NCT06783829
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2025-01-22
Primary completion
2027-03-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.